James Nisco
Director Financiero/CFO en LISATA THERAPEUTICS, INC. .
Fortuna: 30 210 $ al 30/04/2024
Perfil
James Nisco is currently the Treasurer, Chief Accounting Officer & SVP-Finance at Lisata Therapeutics, Inc. He previously worked as the Vice President-Finance & Treasury at Caladrius Biosciences, Inc. Mr. Nisco completed his undergraduate degree at State University of New York College at Oneonta and holds an MBA from Pace University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
15/04/2024 | 11 357 ( 0.14% ) | 30 210 $ | 30/04/2024 |
Cargos activos de James Nisco
Empresas | Cargo | Inicio |
---|---|---|
LISATA THERAPEUTICS, INC. | Director Financiero/CFO | 01/08/2020 |
Antiguos cargos conocidos de James Nisco.
Empresas | Cargo | Fin |
---|---|---|
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Director Financiero/CFO | - |
Formación de James Nisco.
Pace University | Masters Business Admin |
State University of New York College at Oneonta | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
LISATA THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- James Nisco